Static Chart Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE Other stock markets 04:00:00 02/07/2026 HKT			5-day change	1st Jan Change
3.460 ^USD	+1.47%		+15.33%	+25.82%

06-03	Perspective Therapeutics Doses First Meningioma Patient in Phase 1/2a Study Cohort	MT
06-03	Perspective Therapeutics Doses First Patient with [212Pb]Vmt-?-Net in Meningioma Cohort of Phase 1/2A Study	CI

Duration

Period